Third Harmonic Bio(US:THRD)2025-04-14 11:00Financial Position - As of March 31, 2025, the company's preliminary unaudited cash, cash equivalents, and restricted cash amount to approximately $272 million[5]. Liquidation and Dissolution - The board of directors unanimously approved the liquidation and dissolution of the company on April 10, 2025[7]. - The company plans to hold its annual meeting on June 5, 2025, to seek stockholder approval for the liquidation and dissolution[8]. - The board reserves the right to abandon the proposed liquidation and dissolution if deemed not in the best interests of the company and its stockholders[8]. - The company intends to file a proxy statement and other relevant materials with the SEC regarding the planned dissolution[10]. Strategic Alternatives - The company is evaluating strategic alternatives to maximize stockholder value, including potential acquisitions or mergers[7]. Risks and Uncertainties - Forward-looking statements regarding the dissolution process involve substantial risks and uncertainties[12]. - The company may face potential tax claims and litigation matters that could impact the dissolution process[13]. - The adequacy of reserves to satisfy obligations during the dissolution is uncertain and subject to change[13]. - The company has not conducted an exhaustive inquiry into all relevant information regarding the dissolution[13].